Biggest changeSee “ Note 3 — Discontinued Operations ” to our consolidated financial statements included in this report for further detail. 41 Results of Operations The following table sets forth our consolidated statements of operations for the periods presented, both in absolute amount and as a percentage of our total revenues for the periods presented: Fiscal Year Ended December 31, 2024 % of revenue 2023 % of revenue Revenues Revenues from underwriting modeling (ICE) $ 6,649,271 34.1 % $ 8,226,852 43.0 % Revenues from fees 12,841,635 65.9 % 10,924,650 57.0 % SMR 9,849,300 50.5 % 8,085,596 42.2 % HI Card 2,992,335 15.4 % 2,839,054 14.8 % Total revenues 19,490,906 100.0 % 19,151,502 100.0 % Cost of revenues 4,051,439 20.8 % 2,303,911 12.0 % Gross profit $ 15,439,467 79.2 % $ 16,847,591 88.0 % Operating expenses Sales and marketing expenses 3,158,257 16.2 % 3,380,375 17.7 % General and administrative expenses 8,477,407 43.5 % 8,079,329 42.2 % Research and development expenses 2,813,899 14.4 % 2,004,796 10.5 % Total operating expenses 14,449,563 74.1 % 13,464,500 70.4 % Other income (expense): Interest income 122,885 0.6 % 40,857 0.2 % Interest expenses (495,000 ) (2.5 )% (2,052 ) (0.0 )% Other income 271,211 1.4 % — — % Total other income (expense), net (100,904 ) (0.5 )% 38,805 0.2 % Income before income tax expense $ 889,000 4.6 % $ 3,421,896 17.8 % Provision for income taxes (218,523 ) (1.1 )% (945,236 ) (4.9 )% Income from continuing operations, net of income taxes 670,477 3.5 % 2,476,660 12.9 % Income from discontinued operations, net of income taxes — — % 1,481,254 7.7 % Net income $ 670,477 3.5 % $ 3,957,914 20.6 % Net income attributable to noncontrolling interests $ — — % $ 1,481,254 7.7 % Net income attributable to common stockholders $ 670,477 3.5 % $ 2,476,660 12.9 % Other Financial Data: Adjusted EBITDA (1) $ 2,270,745 11.7 % $ 4,799,125 25.1 % (1) We define adjusted EBITDA as income from continuing operations, net of income taxes before net interest expense, taxes, and depreciation and amortization expense, adjusted to eliminate stock-based compensation expense and public company readiness costs deemed not capitalizable.
Biggest changeWe continually review the need for, and the adequacy of, valuation allowances, and recognize benefits from our deferred tax assets only when an analysis of both positive and negative factors indicates that it is more likely than not such benefits will be realized. 41 Results of Operations The following table sets forth our consolidated statements of operations for the periods presented, both in absolute amount and as a percentage of our total revenues for the periods presented: Fiscal Year Ended December 31, 2025 % of revenue 2024 % of revenue Revenues Revenues from underwriting modeling (ICE) $ 6,864,545 20.6 % $ 6,649,271 34.1 % Revenues from fees 26,462,966 79.4 % 12,841,635 65.9 % SMR 26,462,966 79.4 % 9,849,300 50.5 % HI Card — — % 2,992,335 15.4 % Total revenues 33,327,511 100.0 % 19,490,906 100.0 % Cost of revenues 12,389,783 37.2 % 4,051,439 20.8 % Gross profit $ 20,937,728 62.8 % $ 15,439,467 79.2 % Operating expenses Sales and marketing expenses 4,185,766 12.6 % 3,158,257 16.2 % General and administrative expenses 13,654,262 41.0 % 8,477,407 43.5 % Research and development expenses 1,569,262 4.7 % 2,813,899 14.4 % Total operating expenses 19,409,290 58.3 % 14,449,563 74.1 % Other income (expense): Interest income 409,922 1.2 % 122,885 0.6 % Interest expenses — — % (495,000 ) (2.5 )% Other income 118,399 0.4 % 271,211 1.4 % Other expense (382,587 ) (1.1 )% — — % Total other income (expense), net 145,734 0.5 % (100,904 ) (0.5 )% Income before income tax expense $ 1,674,172 5.0 % $ 889,000 4.6 % Provision for income taxes (395,330 ) (1.2 )% (218,523 ) (1.1 )% Net income $ 1,278,842 3.8 % $ 670,477 3.5 % Other Financial Data: Adjusted EBITDA (1) $ 4,112,833 12.3 % $ 2,270,745 11.7 % (1) We define adjusted EBITDA as net income before net interest expense, taxes and amortization expense, adjusted to eliminate stock-based compensation expense and provision for credit losses on other receivables.
Customizable Solutions: Beyond policy underwriting and sales, our marketplace offers customization of health benefits plans, vendors, claims, and network services. Brokers can select customized plans that suit their customers. Accessibility and Savings: We make self-funded benefits plan and stop loss insurance accessible online for small businesses.
Customizable Solutions: Beyond policy underwriting and sales, our marketplace offers customization of health benefits plans, vendors, claims, and network services. Brokers can select customized plans that suit their customers. Accessibility and Savings: We make self-funded benefits plan and stop loss insurance accessible online for businesses.
The fee varies depending on the type of program selected by the broker. SMR’s fees are paid by small employers. (ii) ICE develops and maintains all underwriting models. It defines risk criteria based on risk guidelines provided by carriers, manages underwriting of risk, manages claims activity, ensures reinsurance reporting, and handles monthly reinsurance filings.
The fee varies depending on the type of program selected by the broker. SMR’s fees are paid by employers. (ii) ICE develops and maintains all underwriting models. It defines risk criteria based on risk guidelines provided by carriers, manages underwriting of risk, manages claims activity, ensures reinsurance reporting, and handles monthly reinsurance filings.
Components of Operating Results Revenues While we generate our revenue primarily from small employers and insurance carriers, we grow our business primarily from offering solutions that streamline sales processes, enhance service delivery, and reduce the sales cycle duration for TPAs, MGUs, and Brokers. We offer our services through our three subsidiaries.
Components of Operating Results Revenues While we generate our revenue primarily from employers and insurance carriers, we grow our business primarily from offering solutions that streamline sales processes, enhance service delivery, and reduce the sales cycle duration for TPAs, MGUs, and Brokers. We offer our services through our three subsidiaries.
(i) SMR is a program manager specializing in customized self-funded benefits programs for small businesses. It creates health plans, selects networks and manages vendors, and sets up benefits plans on the marketplace, including benefits structures, coverage options, and provider networks. Licensed brokers log in to the marketplace to select and sell self-funded benefits plans to small businesses.
(i) SMR is a program manager specializing in customized self-funded benefits programs for businesses. It creates health plans, selects networks and manages vendors, and sets up benefits plans on the marketplace, including benefits structures, coverage options, and provider networks. Licensed brokers log in to the marketplace to select and sell self-funded benefits plans to businesses.
(iii) HI Card provides medical claims access data and claims negotiation for SMR’s program members who select such services and provides 24/7 accessibility to all incurred medical data for employees who enroll in the HI Card service. Accordingly, all of the revenue we generate from HI Card is from SMR’s program members, which are enrolled employees of the small employer.
(iii) HI Card provides medical claims access data and claims negotiation for SMR’s program members who select such services and provides 24/7 accessibility to all incurred medical data for employees who enroll in the HI Card service. Accordingly, all of the revenue we generate from HI Card is from SMR’s program members, which are enrolled employees of the employer.
Brokers that utilize the program services on behalf of the small employer provided by SMR and MGU activities provided by ICE, are not obligated to utilize our HI Card service. Currently ICE does not offer underwriting services as a standalone service. In the future, we may consider offering it as a standalone service.
Brokers that utilize the program services on behalf of the employer provided by SMR and MGU activities provided by ICE, are not obligated to utilize our HI Card service. Currently ICE does not offer underwriting services as a standalone service. In the future, we may consider offering it as a standalone service.
While we generate our revenue primarily from small employers and insurance carriers, we currently derive substantially all of our business through brokers, TPAs, and other third-party agents who provide referrals. As a result, the size of our network is critical to our success.
While we generate our revenue primarily from employers and insurance carriers, we currently derive substantially all of our business through brokers, TPAs, and other third-party agents who provide referrals. As a result, the size of our network is critical to our success.
The revenue generated from HI Card is derived from a set fee charged per enrolled employee (EE) per month (PEPM). The fee may vary depending on services or the network selected by the broker. Brokers are not obligated to utilize the HI Card service for the small employers.
The revenue generated from HI Card is derived from a set fee charged per enrolled employee (EE) per month (PEPM). The fee may vary depending on services or the network selected by the broker. Brokers are not obligated to utilize the HI Card service for the employers.
We aim to deliver meaningful cost savings for low-risk, small employers with comparatively healthy employees through a digital medical underwriting process. We seek to deliver time savings for employers, brokers, TPAs, and carriers, by leveraging both external and internally developed technology.
We aim to deliver meaningful cost savings for low-risk employers with comparatively healthy employees through a digital medical underwriting process. We seek to deliver time savings for employers, brokers, TPAs, and carriers, by leveraging both external and internally developed technology.
Cash provided by operating activities for the year ended December 31, 2024, principally resulted from our income from continuing operations, net of income taxes $0.7 million, $1.3 million in adjustments for non-cash items primarily related to amortization, amortization of debt discount and stock-based compensation expense, and $0.2 million of cash provided by changes in working capital, including a decrease in accounts receivable of $0.6 million, a decrease in other receivables of $1.2 million, an increase in prepaid expenses and other current assets of $0.5 million, a decrease in accounts payable and accrued expenses of $0.9 million and a decrease in income taxes payable of $0.2 million.
Cash provided by operating activities for the year ended December 31, 2024, principally resulted from our net income of $0.7 million, $1.3 million in adjustments for non-cash items primarily related to amortization, amortization of debt discount and stock-based compensation expense, and $0.2 million of cash provided by changes in working capital, including a decrease in accounts receivable of $0.6 million, a decrease in other receivables of $1.2 million, an increase in prepaid expenses and other current assets of $0.5 million, a decrease in accounts payable and accrued expenses of $0.9 million and a decrease in income taxes payable of $0.2 million.
Our cash and cash equivalents as of December 31, 2024 were held in order to fund our working capital needs. We do not enter into investments for trading or speculative purposes. Our policy is to invest any cash in excess of our immediate requirements in investments designed to preserve the principal balance and provide liquidity.
Our cash and cash equivalents as of December 31, 2025 were held in order to fund our working capital needs. We do not enter into investments for trading or speculative purposes. Our policy is to invest any cash in excess of our immediate requirements in investments designed to preserve the principal balance and provide liquidity.
References herein to emerging growth company will have the meaning associated with it in the JOBS Act. 48
References herein to emerging growth company will have the meaning associated with it in the JOBS Act.
In addition, we continued to maintain profitability while driving revenue growth of 2% year over year from fiscal year 2023 to fiscal year 2024. We currently generate most of our revenue from service fees and underwriting fees, that are associated with customers who purchase self-funded benefits plans and stop loss insurance.
In addition, we continued to maintain profitability while driving revenue growth of 71% year over year from fiscal year 2024 to fiscal year 2025. We currently generate most of our revenue from service fees and underwriting fees, that are associated with customers who purchase self-funded benefits plans and stop loss insurance.
By removing friction and complexities, we streamline the underwriting, sales and service process for insurance companies, licensed brokers, and TPAs. Marketplace: We are a health insurance marketplace where insurance companies can list various stop-loss policy options for self-funded benefits plans.
By removing friction and complexities, we streamline the underwriting, sales and service process for insurance companies, licensed brokers, Managing General Underwriters (MGUs) and TPAs. Marketplace: We are a health insurance marketplace where insurance companies can list various stop-loss policy options for self-funded benefits plans.
See “Item 1A. Risk Factors — Risks Related to our Business and Industry” for additional information on the risks associated with our service offerings. Sales and marketing expenses Sales and marketing expenses primarily consist of personnel-related costs including salaries, benefits and commissions cost for our sales and marketing personnel.
See “Item 1A. Risk Factors — Risks Related to our Business and Industry” for additional information on the risks associated with our service offerings. Sales and marketing expenses Sales and marketing expenses primarily consist of personnel-related costs including salaries, stock-based compensation expense, benefits and commissions cost for our sales and marketing personnel.
Our service fee is billed to such business customers on a per enrolled employee (EE) per month (PEPM) basis, which ranges from $2 to $35 based on selected services for each small business, and our underwriting revenue is a percentage of monthly premium paid on a PEPM basis.
Our service fee is billed to such business customers on a per enrolled employee (EE) per month (PEPM) basis, which ranges from $2 to $50 based on selected services — and generates underwriting revenue as a percentage of the monthly premium paid on a PEPM basis.
Please refer to “ Summary Consolidated Financial Data — Adjusted EBITDA” in this Report for a discussion of the limitations of adjusted EBITDA and reconciliations of adjusted EBITDA to income from continuing operations, net of income taxes, the most comparable GAAP measurements, respectively, for the years ended December 31, 202 4 and 2023.
Please refer to “ Summary Consolidated Financial Data — Adjusted EBITDA” in this Report for a discussion of the limitations of adjusted EBITDA and reconciliations of adjusted EBITDA to net income, the most comparable GAAP measurements, respectively, for the years ended December 31, 2025 and 2024.
As a percentage of revenue, cost of revenues increased to 20.8% for the year ended December 31, 2024, from 12.0% for the same period in 2023.
As a percentage of revenue, cost of revenues increased to 37.2% for the year ended December 31, 2025, from 20.8% for the same period in 2024.
HI Card’s fees are paid by small employers. 40 The following table sets forth the components of our revenues by subsidiaries and percentages of our total revenues for the periods presented: Fiscal Year Ended December 31, 2024 % of revenue 2023 % of revenue Revenues Revenues from underwriting modeling (ICE) $ 6,649,271 34.1 % $ 8,226,852 43.0 % Revenues from fees 12,841,635 65.9 % 10,924,650 57.0 % SMR 9,849,300 50.5 % 8,085,596 42.2 % HI Card 2,992,335 15.4 % 2,839,054 14.8 % Total revenues 19,490,906 100.0 % 19,151,502 100.0 % Cost of revenues Cost of revenues primarily consists of infrastructure costs to operate our platform such as hosting fees and fees paid to various third-party partners for access to their technology, services and amortization expenses of our capitalized internal-use software related to our platform.
HI Card’s fees are paid by employers. 40 The following table sets forth the components of our revenues by subsidiaries and percentages of our total revenues for the periods presented: Fiscal Year Ended December 31, 2025 % of revenue 2024 % of revenue Revenues Revenues from underwriting modeling (ICE) $ 6,864,545 20.6 % $ 6,649,271 34.1 % Revenues from fees 26,462,966 79.4 % 12,841,635 65.9 % SMR 26,462,966 79.4 % 9,849,300 50.5 % HI Card — — % 2,992,335 15.4 % Total revenues 33,327,511 100.0 % 19,490,906 100.0 % Cost of revenues Cost of revenues primarily consists of infrastructure costs to operate our platform such as hosting fees and fees paid to various third-party partners for access to their technology, services and amortization expenses of our capitalized internal-use software related to our platform.
Investing Activities Cash used in investing activities decreased by $1.1 million to $0.8 million for the year ended December 31, 2024, compared to $1.9 million for the year ended December 31, 2023.
Investing Activities Cash used in investing activities increased by $2.3 million to $3.1 million for the year ended December 31, 2025, compared to $0.8 million for the year ended December 31, 2024.
Cash provided by operating activities for the year ended December 31, 2023 principally resulted from our income from continuing operations, net of income taxes $2.5 million, $0.5 million in adjustments for non-cash items primarily related to amortization and deferred tax expenses, and offset by $1.5 million of cash used to fund changes in working capital, including an increase in accounts receivable of $1.3 million, an increase in other receivables of $1.7 million, a decrease in due to discontinued operations of $0.7 million and an increase in accounts payable and accrued expenses of $2.1 million.
Cash provided by operating activities for the year ended December 31, 2025, principally resulted from our net income of $1.3 million, $7.0 million in adjustments for non-cash items primarily related to amortization, provision for refund liability and stock-based compensation expense, and offset by $5.2 million of cash used to fund changes in working capital, including a decrease in accounts receivable of $0.9 million, an increase in other receivables for Deferred Administrative Surplus of $3.3 million, an increase in prepaid expenses and other assets of $2.0 million, an increase in accounts payable and accrued expenses of $2.4 million, a decrease in income taxes payable of $0.2 million and a decrease in other current liabilities of $3.0 million.
JOBS Act We are an emerging growth company, as defined in the Jumpstart Our Business Startups Act of 2012, or the JOBS Act. Under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards issued subsequent to the enactment of the JOBS Act until such time as those standards apply to private companies.
Under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards issued subsequent to the enactment of the JOBS Act until such time as those standards apply to private companies.
As of December 31, 2024, we had clients in 41 states, with our services and platforms actively utilized by 417 brokers, 11 Third-Party Administrators (TPAs), and 212 additional third-party agencies. Our stop loss insurance policies for self-funded benefits plans were sold to 890 business clients with 18,348 employees.
As of December 31, 2025, we had clients in 40 states, with our services and platforms actively utilized by 583 brokers, 12 Third-Party Administrators (TPAs), and 263 additional third-party agencies. Our stop loss insurance policies for self-funded benefits plans were sold to 795 business clients with 22,515 employees.
Summary of Cash Flows — Continuing Business Fiscal Year Ended December 31, 2024 2023 Cash provided by (used in): Operating activities $ 2,176,209 $ 1,484,527 Investing activities (836,755 ) (1,944,361 ) Financing activities 4,093,444 1,388,231 Increase in cash and cash equivalents $ 5,432,898 $ 928,397 Operating Activities Net cash provided by operating activities increased by $0.7 million to $2.2 million for the year ended December 31, 2024, compared to $1.5 million for the same period in 2023, primarily due to process improvements and the automation of our accounts receivable (AR) system.
Summary of Cash Flows Fiscal Year Ended December 31, 2025 2024 Cash provided by (used in): Operating activities $ 3,133,813 $ 2,176,209 Investing activities (3,125,921 ) (836,755 ) Financing activities (187,386 ) 4,093,444 Increase (Decrease) in cash and cash equivalents $ (179,494 ) $ 5,432,898 Operating Activities Net cash provided by operating activities increased by $0.9 million to $3.1 million for the year ended December 31, 2025, compared to $2.2 million for the same period in 2024, primarily due to the growth in revenues, process improvements and the automation of our accounts receivable (AR) system.
Cost of revenues Fiscal Year Ended December 31, 2024 2023 Period-to-Period Change Amount Percentage of Revenue Amount Percentage of Revenue Amount Percentage of Revenue Cost of revenues 4,051,439 20.8 % 2,303,911 12.0 % 1,747,528 8.8 % Cost of revenues increased by $1.7 million to $4.0 million for the year ended December 31, 2024, from $2.3 million for the year ended December 31, 2023.
Cost of revenues Fiscal Year Ended December 31, 2025 2024 Period-to-Period Change Amount Percentage of Revenue Amount Percentage of Revenue Amount Percentage of Revenue Cost of revenues 12,389,783 37.2 % 4,051,439 20.8 % 8,338,344 16.4 % Cost of revenues increased by $8.4 million to $12.4 million for the year ended December 31, 2025, from $4.0 million for the year ended December 31, 2024.
This decrease was primarily due to the higher operating expenses mainly driven by the increase in experienced high caliber managers. 46 Liquidity and Capital Resources Sources of Liquidity To date, we have funded our operations primarily through cash from operating activities, short-term loans, our IPO completed in December 2024, and our issuance of Series A Convertible Preferred Stock for $2 million to an institutional investor, which was converted in to shares of Class A Common Stock in August 2023 on a one for one basis.
The increase in adjusted EBITDA was primarily attributable to robust revenue growth, driven by strong demand for our new product offerings facilitated by continued channel expansion through brokers, TPAs, and agencies. 46 Liquidity and Capital Resources Sources of Liquidity To date, we have funded our operations primarily through cash from operating activities, short-term loans, our IPO completed in December 2024, and our issuance of Series A Convertible Preferred Stock for $2 million to an institutional investor, which was converted into shares of Class A Common Stock in August 2023 on a one for one basis.
Provision for income taxes Fiscal Year Ended December 31, 2024 2023 Period-to-Period Change Amount Percentage of Revenue Amount Percentage of Revenue Amount Percentage of Revenue Provision for income taxes (218,523 ) (1.1 )% (945,236 ) (4.9 )% 726,713 3.8 % Provision for income taxes decreased by $0.7 million to $0.2 million for the year ended December 31, 2024, from $0.9 million for the year ended December 31, 2023.
Provision for income taxes Fiscal Year Ended December 31, 2025 2024 Period-to-Period Change Amount Percentage of Revenue Amount Percentage of Revenue Amount Percentage of Revenue Provision for income taxes (395,330 ) (1.2 )% (218,523 ) (1.1 )% (176,807 ) (0.1 )% Provision for income taxes increased by $0.2 million to $0.4 million for the year ended December 31, 2025, from $0.2 million for the year ended December 31, 2024.
Adjusted EBITDA Adjusted EBITDA represents our earnings from continuing operations before net interest expense, taxes, and depreciation and amortization expense, adjusted to eliminate stock-based compensation expense and public company readiness costs not deemed capitalizable. Adjusted EBITDA is not a measure calculated in accordance with United States Generally Accepted Accounting Principles, or GAAP.
Adjusted EBITDA Adjusted EBITDA represents our net income before net interest expense, taxes and amortization expense, adjusted to eliminate stock-based compensation and provision for credit losses on other receivables. Adjusted EBITDA is not a measure calculated in accordance with United States Generally Accepted Accounting Principles, or GAAP.
Adjusted EBITDA Fiscal Year Ended December 31, 2024 2023 Period-to-Period Change Amount Percentage of Revenue Amount Percentage of Revenue Amount Percentage of Revenue Adjusted EBITDA 2,270,745 11.7 % 4,799,125 25.1 % (2,528,380 ) (13.4 )% Adjusted EBITDA decreased by $2.5 million to $2.3 million for the year ended December 31, 2024, from $4.8 million for the year ended December 31, 2023.
Adjusted EBITDA Fiscal Year Ended December 31, 2025 2024 Period-to-Period Change Amount Percentage of Revenue Amount Percentage of Revenue Amount Percentage of Revenue Adjusted EBITDA 4,112,833 12.3 % 2,270,745 11.7 % 1,842,088 0.6 % Adjusted EBITDA increased by $1.8 million to $4.1 million for the year ended December 31, 2025, from $2.3 million for the year ended December 31, 2024.
As a percentage of revenue, adjusted EBITDA decreased to 11.7% for the year ended December 31, 2024, from 25.1% for the same period in 2023.
As a percentage of revenue, adjusted EBITDA was 12.3% for the year ended December 31, 2025, representing a modest increase compared to 11.7% for the same period in 2024.
These metrics help us develop and refine our growth strategies and make strategic decisions. We discuss revenues, cost of revenues, and the components of operating expenses. We utilize other key metrics as described below. Number of Enrolled Employees (EEs) Medical Health Plan Billed Our primary customers are small businesses, which can have anywhere from 5 to 150 employees.
These metrics help us develop and refine our growth strategies and make strategic decisions. We discuss revenues, cost of revenues, and the components of operating expenses. We utilize other key metrics as described below.
The accounts receivable turnover period for the year ended December 31, 2024 was 29 days, representing a 13-day reduction from 42 days for the year ended December 31, 2023. Other receivables As of December 31, 2024, the balance of other receivables decreased by $1,180,848 to $500,252, from $1,681,100 as of December 31, 2023.
The accounts receivable turnover period for the year ended December 31, 2025 was 14 days, representing a 15-day reduction from 29 days for the year ended December 31, 2024. Other receivables, net As of December 31, 2025, the net other receivables increased by $2,967,562 to $3,467,814, from $500,252 as of December 31, 2024.
Please refer to our Consolidated Statements of Changes in Stockholders’ Equity for additional information.
This increase was mainly attributable to our net income and stock-based compensation. Please refer to our Consolidated Statements of Changes in Stockholders’ Equity for additional information.
Research and development expenses Research and development expenses primarily consist of personnel-related costs, including salaries and benefits for our research and development personnel. Additional expenses include costs related to the software development, quality assurance, and testing of new technology, and enhancement of our existing platform technology.
Research and development expenses Research and development expenses primarily consist of personnel-related costs, including salaries, stock-based compensation expense and benefits for our research and development personnel. Additional expenses include costs related to research, design, and preliminary planning of new technology, as well as routine maintenance of its existing platform.
As a percentage of revenue, general and administrative expenses increased to 43.5% for the year ended December 31, 2024, from 42.2% for the same period in 2023. We bifurcate general and administrative expenses as follows: Administrative division — The administrative division mainly represents payroll and benefits expenses incurred related to Executives, Human Resources, Accounting, and Finance related personnel.
Administrative division — The administrative division mainly represents payroll, stock-based compensation expense and benefits expenses incurred related to Executives, Human Resources, Accounting, and Finance related personnel. General and administrative expenses increased by $5.2 million to $13.7 million for the year ended December 31, 2025, from $8.5 million for the year ended December 31, 2024.
Accounts receivable, net As of December 31, 2024, the balance of accounts receivable decreased by $588,563 to $1,647,103, from $2,235,666 as of December 31, 2023. This decrease was mainly attributable to process improvements and the automation of our accounts receivable (AR) system.
Accounts receivable, net As of December 31, 2025, the net accounts receivable decreased by $890,815 to $756,288, from $1,647,103 as of December 31, 2024. This reduction mainly resulted from process enhancements and automation of our accounts receivable (AR) process.
See “ Adjusted EBITDA ” below for more information and for a reconciliation of adjusted EBITDA to income from continuing operations, net of income taxes, the most directly comparable financial measure calculated and presented in accordance with GAAP. 42 Adjusted EBITDA Fiscal Year Ended December 31, 2024 2023 Reconciliation from Income from Continuing Operations, Net of Income Taxes to Adjusted EBITDA: Income from continuing operations, net of income taxes $ 670,477 $ 2,476,660 Interest (income) expenses 372,115 (38,805 ) Depreciation and amortization 541,141 339,300 Income tax expense 218,523 945,236 Stock-based compensation expense 468,489 — Public company readiness costs deemed not capitalizable — 1,076,734 Total net adjustments 1,600,268 2,322,465 Adjusted EBITDA $ 2,270,745 $ 4,799,125 Consolidated Balance Sheet Data December 31, 2024 2023 Cash and cash equivalents $ 7,849,248 $ 2,416,350 Accounts receivable, net 1,647,103 2,235,666 Other receivables 500,252 1,681,100 Software 3,962,461 3,561,385 Total assets 15,768,489 11,503,292 Total liabilities 2,599,461 5,410,066 Total stockholders’ equity 13,169,028 6,093,226 Cash and cash equivalents As of December 31, 2024, the balance of cash and cash equivalents increased by $5,432,898 to $7,849,248, from $2,416,350 as of December 31, 2023.
See “ Adjusted EBITDA ” below for more information and for a reconciliation of adjusted EBITDA to net income, the most directly comparable financial measure calculated and presented in accordance with GAAP. 42 Adjusted EBITDA Fiscal Year Ended December 31, 2025 2024 Reconciliation from Net Income to Adjusted EBITDA: Net income $ 1,278,842 $ 670,477 Interest (income) expenses (409,922 ) 372,115 Amortization expense 900,577 541,141 Income tax expense 395,330 218,523 Stock-based compensation expense 1,570,419 468,489 Provision for credit losses on other receivables 377,587 — Total net adjustments 2,833,991 1,600,268 Adjusted EBITDA $ 4,112,833 $ 2,270,745 Consolidated Balance Sheet Data December 31, 2025 2024 Cash and cash equivalents $ 7,669,754 $ 7,849,248 Accounts receivable, net 756,288 1,647,103 Other receivables, net 3,467,814 500,252 Software 6,530,894 3,962,461 Total assets 23,089,961 15,768,489 Total liabilities 5,977,896 2,599,461 Total stockholders’ equity 17,112,065 13,169,028 Cash and cash equivalents As of December 31, 2025, the balance of cash and cash equivalents was $7,669,754, remaining relatively stable compared to $7,849,248 as of December 31, 2024.
As a percentage of revenue, sales and marketing expenses decreased to 16.2% for the year ended December 31, 2024, compared to 17.7% for the same period in 2023.
However, as a percentage of revenue, general and administrative expenses decreased to 41.0% for the year ended December 31, 2025, from 43.5% for the same period in 2024.
Comparison of Years Ended December 31, 2024 and 2023 Revenues Fiscal Year Ended December 31, 2024 2023 Period-to-Period Change Amount Percentage of Revenue Amount Percentage of Revenue Amount Percentage Revenues from underwriting modeling (ICE) 6,649,271 34.1 % 8,226,852 43.0 % (1,577,581 ) (19.2 )% Revenues from fees 12,841,635 65.9 % 10,924,650 57.0 % 1,916,985 17.5 % SMR 9,849,300 50.5 % 8,085,596 42.2 % 1,763,704 21.8 % HI Card 2,992,335 15.4 % 2,839,054 14.8 % 153,281 5.4 % Total revenues 19,490,906 100.0 % 19,151,502 100.0 % 339,404 1.8 % Revenues increased by $0.3 million, or 1.8%, to $19.5 million for the year ended December 31, 2024, from $19.2 million for the year ended December 31, 2023.
Comparison of the Years Ended December 31, 2025 and 2024 Revenues Fiscal Year Ended December 31, 2025 2024 Period-to-Period Change Amount Percentage of Revenue Amount Percentage of Revenue Amount Percentage Revenues from underwriting modeling (ICE) 6,864,545 20.6 % 6,649,271 34.1 % 215,274 3.2 % Revenues from fees 26,462,966 79.4 % 12,841,635 65.9 % 13,621,331 106.1 % SMR 26,462,966 79.4 % 9,849,300 50.5 % 16,613,666 168.7 % HI Card — — % 2,992,335 15.4 % (2,992,335 ) (100.0 )% Total revenues 33,327,511 100.0 % 19,490,906 100.0 % 13,836,605 71.0 % Revenues increased by $13.8 million, or 71.0%, to $33.3 million for the year ended December 31, 2025, from $19.5 million for the year ended December 31, 2024.
Licensed brokers registered on our platform can log in, upload certain required information, select policy plans, obtain a bindable quote and sell them to small businesses. In most cases, our technology enables us to medically underwrite insurance policies and produce bindable quotes within about two minutes, allowing us to deliver an integrated and seamless sales cycle.
Licensed brokers registered on our platform can log in, upload certain required information, select policy plans, obtain a bindable quote and sell them to businesses.
This increase was mainly attributable to a $927,868 investment in new software development and a $14,349 increase in completed existing software, partially offset by a $541,141 increase in accumulated amortization for the year ended December 31, 2024.
This increase was mainly attributable to a $3,469,010 investment in the expansion of eDIYBS systems and new software development, partially offset by a $900,577 increase in accumulated amortization for the year ended December 31, 2025. The expansion of eDIYBS systems to serve large size employers was completed in September 2025 .
Net cash provided by financing activities for the year ended December 31, 2023 principally resulted from $1.7 million in proceeds from short-term loans and partially offset by $0.3 million in payments of deferred offering costs. Contractual Obligations and Commitments Our principal commitments consist of obligations under our non-cancellable lease for our office.
Cash used in financing activities for the year ended December 31, 2024 consisted primarily of $2.0 million payments of deferred offering costs and $2.1 million repayments of notes payable. Contractual Obligations and Commitments Our principal commitments consist of obligations under our non-cancellable lease for our office. The following table summarizes the contractual obligation as of December 31, 2025.
We adopted this standard effective January 1, 2024 using a retrospective method. We do not believe that any other recently issued but not yet effective accounting pronouncements are expected to have a material effect on our consolidated financial statements.
We do not believe that any other recently issued but not yet effective accounting pronouncements are expected to have a material effect on our consolidated financial statements. 48 JOBS Act We are an emerging growth company, as defined in the Jumpstart Our Business Startups Act of 2012, or the JOBS Act.
This decrease was mainly attributable to the collection of $1,269,595 from Deferred Administrative Surplus for the year ended December 31, 2024. 43 Software As of December 31, 2024, the balance of software increased by $401,076 to $3,962,461, from $3,561,385 as of December 31, 2023.
This increase was mainly attributable to the purchase of Deferred Administrative Surplus for $3,481,684 on March 18, 2025. 43 Software As of December 31, 2025, the balance of software increased by $2,568,433 to $6,530,894, from $3,962,461 as of December 31, 2024.
Income from discontinued operations, net of income taxes Fiscal Year Ended December 31, 2024 2023 Period-to-Period Change Amount Percentage of Revenue Amount Percentage of Revenue Amount Percentage of Revenue Income from discontinued operations, net of income taxes — — % 1,481,254 7.7 % (1,481,254 ) (7.7 )% Income from discontinued operations, net of income taxes, was $1.5 million for the year ended December 31, 2023.
Income before income tax expense Fiscal Year Ended December 31, 2025 2024 Period-to-Period Change Amount Percentage of Revenue Amount Percentage of Revenue Amount Percentage of Revenue Income before income tax expense 1,674,172 5.0 % 889,000 4.6 % 785,172 0.4 % Income before income tax expense increased by $0.8 million to $1.7 million for the year ended December 31, 2025, from $0.9 million for the year ended December 31, 2024.
The following table sets forth the number of EEs billed for the periods indicated: Fiscal Year Ended December 31, Period-to-Period Change 2024 2023 EEs Percentage Number of EEs billed (End of period) 18,348 21,213 (2,865 ) (14 )% 39 In 2024, we diversified the stop loss policies offering, by adding new carriers.
The following table sets forth the number of EEs billed for the periods indicated: Fiscal Year Ended December 31, Period-to-Period Change 2025 2024 EEs Percentage Number of EEs billed (End of period) 22,515 18,348 4,167 23 % 39 As of December 31, 2025, the number of enrolled employees reached 22,515, representing a 23% increase from 18,348 in the same period of 2024.
The increase was primarily driven by $8.2 million in net proceeds from the issuance of Class A common stock in connection with our IPO. However, this was partially offset by $2.0 million in payments of deferred offering cost and $2.1 million in repayments of notes payable.
The decrease was primarily driven by $8.2 million in proceeds from the issuance of Class A common stock in connection with our IPO during 2024, net of underwriting discounts and commissions. Cash used in financing activities for the year ended December 31, 2025 consisted primarily of payments of deferred offering costs for our public offering.
Offsetting these increases, public company readiness costs not deemed capitalizable decreased by approximate $1.1 million in 2024, as a significant portion of our public company preparation work was completed in 2023. 45 Research and development expenses Fiscal Year Ended December 31, 2024 2023 Period-to-Period Change Amount Percentage of Revenue Amount Percentage of Revenue Amount Percentage of Revenue Research and development expenses 2,813,899 14.4 % 2,004,796 10.5 % 809,103 3.9 % Research and development expenses increased by $0.8 million to $2.8 million for the year ended December 31, 2024, from $2.0 million for the year ended December 31, 2023.
This decrease was primarily attributable to the improved operating leverage in our operations division, which was partially offset by increased expenses associated with being a public company. 45 Research and development expenses Fiscal Year Ended December 31, 2025 2024 Period-to-Period Change Amount Percentage of Revenue Amount Percentage of Revenue Amount Percentage of Revenue Research and development expenses 1,569,262 4.7 % 2,813,899 14.4 % (1,244,637 ) (9.7 )% Research and development expenses that are not associated with software developments decreased by $1.2 million to $1.6 million for the year ended December 31, 2025, from $2.8 million for the year ended December 31, 2024.
The primary use of cash used in investing activities in 2024 were related to the development of our internal-use software, reflecting our continued investment in enhancing all our technology platforms.
The primary use of cash used in investing activities in 2025 and 2024 was related to the development of our proprietary AI-enabled platform, reflecting our continued investment in enhancing all our technology platforms. 47 Financing Activities Net cash used in financing activities was $0.2 million for the year ended December 31, 2025, compared to $4.1 million of net cash provided by financing activities for the year ended December 31, 2024.
As a percentage of revenue, research and development expenses increased to 14.4% for the year ended December 31, 2024, compared to 10.5% for the same period in 2023. This increase was primarily attributable to the increase in personnel-related costs related to IT compliance, IT information security and new product service research and development.
As a percentage of revenue, research and development expenses decreased to 4.7% for the year ended December 31, 2025, compared to 14.4% for the same period in 2024. The costs associated with software developments that are capitalized increased by $1.7 million to $2.1 million for the year ended December 31, 2025, from $0.4 million for the same period in 2024.
These plans are facilitated through a network of brokers, TPAs, MGUs, carriers, and other third-party agents. These agencies either directly engage our services or provide valuable client referrals. Roscommon Insurance Company (“Roscommon”) and Roscommon Captive Management LLC, the self-insurance carrier business, previously owned by our Chief Executive Officer, Mr.
These plans are facilitated through a network of brokers, TPAs, MGUs, carriers, and other third-party agents. These agencies either directly engage our services or provide valuable client referrals. Recent Developments Engaged Amazon Web Services (AWS) Advanced Tier Services Partner Ciklum to accelerate development of Health In Tech’s AI-Driven InsurTech platform.
Sales and marketing expenses Fiscal Year Ended December 31, 2024 2023 Period-to-Period Change Amount Percentage of Revenue Amount Percentage of Revenue Amount Percentage of Revenue Sales and marketing expenses 3,158,257 16.2 % 3,380,375 17.7 % (222,118 ) (1.5 )% Sales and marketing expense decreased by 0.2 million to $3.2 million for the year ended December 31, 2024, compared to 3.4 million for the year ended December 31, 2023.
The increase was primarily attributable to higher captive management fees related to the new products and new channels launched in July 2024, as we continued to expand our business scale. 44 Sales and marketing expenses Fiscal Year Ended December 31, 2025 2024 Period-to-Period Change Amount Percentage of Revenue Amount Percentage of Revenue Amount Percentage of Revenue Sales and marketing expenses 4,185,766 12.6 % 3,158,257 16.2 % 1,027,509 (3.6 )% Sales and marketing expenses increased by 1.0 million to $4.2 million for the year ended December 31, 2025, compared to $3.2 million for the year ended December 31, 2024.
Total liabilities As of December 31, 2024, the balance of total liabilities decreased by $2,810,605 to $2,599,461, from $5,410,066 as of December 31, 2023.
Total liabilities As of December 31, 2025, the balance of total liabilities increased by $3,378,435 to $5,977,896, from $2,599,461 as of December 31, 2024. This increase was driven by the higher accounts payable and accrued expenses reflecting the expansion of our business scale.
General and administrative expenses Fiscal Year Ended December 31, 2024 2023 Period-to-Period Change Amount Percentage of Revenue Amount Percentage of Revenue Amount Percentage of Revenue General and administrative expenses: Operations division 4,380,589 22.5 % 3,262,253 17.0 % 1,118,336 5.5 % Administrative division 4,096,818 21.0 % 3,740,342 19.6 % 356,476 1.4 % Public company readiness costs not deemed capitalizable — — % 1,076,734 5.6 % (1,076,734 ) (5.6 )% Total General and administrative expenses 8,477,407 43.5 % 8,079,329 42.2 % 398,078 1.3 % General and administrative expenses increased by $0.4 million to $8.5 million for the year ended December 31, 2024, from $8.1 million for the year ended December 31, 2023.
General and administrative expenses Fiscal Year Ended December 31, 2025 2024 Period-to-Period Change Amount Percentage of Revenue Amount Percentage of Revenue Amount Percentage of Revenue General and administrative expenses: Operations division 5,253,471 15.8 % 4,380,589 22.5 % 872,882 (6.7 )% Administrative division 8,400,791 25.2 % 4,096,818 21.0 % 4,303,973 4.2 % Total General and administrative expenses 13,654,262 41.0 % 8,477,407 43.5 % 5,176,855 (2.5 )% We bifurcate general and administrative expenses as follows: Operations division — The operations division mainly consists of payroll, stock-based compensation expense and benefits expenses incurred related to our underwriting, claims management, operations development, enrollment, nursing and strategic program development personnel.